Cleared Traditional

INJECTION PIN (KIP(02031-02061) (03031-03061)) (K221697) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
266d
Days
Class 2
Risk

K221697 is an FDA 510(k) clearance for the INJECTION PIN (KIP(02031-02061) (03031-03061)). Classified as Cement, Bone, Vertebroplasty (product code NDN), Class II - Special Controls.

Submitted by Slk Ortho, LLC (Long Grove, US). The FDA issued a Cleared decision on March 3, 2023 after a review of 266 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3027 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Slk Ortho, LLC devices

Submission Details

510(k) Number K221697 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 10, 2022
Decision Date March 03, 2023
Days to Decision 266 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
144d slower than avg
Panel avg: 122d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NDN Cement, Bone, Vertebroplasty
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3027
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - NDN Cement, Bone, Vertebroplasty

All 36
Devices cleared under the same product code (NDN) and FDA review panel - the closest regulatory comparables to K221697.
Balloon Inflation System
K232842 · Ningbo Hicren Biotechnology Co., Ltd. · Feb 2024
V-STRUT® Vertebral Implant
K240084 · Hyprevention · Feb 2024
Renova Spine Balloon Catheter
K231340 · Biopsybell S.R.L. · Oct 2023
SpineJack® Expansion Kit
K223294 · Stryker Instruments · Dec 2022
KYPHON VuE Bone Cement
K220131 · Tecres S.P.A. · Apr 2022
TRACKER Plus Kyphoplasty System
K211797 · GS Medical Co., Ltd. · Oct 2021